JPMorgan upgraded Allient to Overweight from Neutral with a price target of $80, up from $65. The firm says the company has evolved from a fragmented motion component supplier into a vertically integrated engineering platform combining motion, controls, and power technologies. Allient offers upside with mid-single-digit long-term growth, ongoing margin improvement, and \"robust positioning\" in long-term secular end markets of defense, automation, and humanoids, the analyst tells investors in a research note.